UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Geht der Trend nun zur Zweierkombination?

MMW Fortschritte der Medizin, 2019-06, Vol.161 (Suppl 2), p.42-46

Heiken, Hans

2019

Link zum Volltext

Verfügbarkeit prüfen

Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study

PloS one, 2021-05, Vol.16 (5), p.e0250833-e0250833

2021

Link zum Volltext

Verfügbarkeit prüfen

CCL2: A potential prognostic marker and target of anti‐inflammatory strategy in HIV/AIDS pathogenesis

European journal of immunology, 2011-12, Vol.41 (12), p.3412-3418

2011

Link zum Volltext

Verfügbarkeit prüfen

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

AIDS research and therapy, 2021-09, Vol.18 (1), p.58-58, Article 58

2021

Link zum Volltext

Verfügbarkeit prüfen

Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

HIV research & clinical practice, 2021-12, Vol.23 (1), p.15-21

2021

Link zum Volltext

Verfügbarkeit prüfen

Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals

International immunology, 2006-10, Vol.18 (10), p.1443-1451

2006

Link zum Volltext

Verfügbarkeit prüfen

Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline

Zeitschrift fur Gastroenterologie, 2011-07, Vol.49 (7), p.871

2011

Link zum Volltext

Verfügbarkeit prüfen

Barriers to hepatitis C virus elimination in Germany: why aren’t diagnosed patients initiating therapy?

Journal of hepatology, 2020-08, Vol.73, p.S795-S796

2020

Link zum Volltext

Verfügbarkeit prüfen

SAT286 - Barriers to hepatitis C virus elimination in Germany: why aren’t diagnosed patients initiating therapy?

Journal of hepatology, 2020-08, Vol.73, p.S795-S796

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of HIV-1 infection: is it time to hit early again?

Expert review of anti-infective therapy, 2008-06, Vol.6 (3), p.273-275

Heiken, Hans

2008

Link zum Volltext

Verfügbarkeit prüfen

Infection with GB Virus C and Reduced Mortality among HIV-Infected Patients

The New England journal of medicine, 2001-09, Vol.345 (10), p.715-724

2001

Link zum Volltext

Verfügbarkeit prüfen

High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study

Infection, 2020-06, Vol.48 (3), p.453-461

2020

Link zum Volltext

Verfügbarkeit prüfen

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany

Infection, 2023-06, Vol.51 (3), p.665-678

2023

Link zum Volltext

Verfügbarkeit prüfen

Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines

Medicine (Baltimore), 2016-06, Vol.95 (26), p.e3961-e3961

2016

Link zum Volltext

Verfügbarkeit prüfen

Reconstitution of NK Cell Activity in HIV-1 Infected Individuals Receiving Antiretroviral Therapy

Immunobiology (1979), 2000-08, Vol.202 (2), p.172-178

2000

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study

Open forum infectious diseases, 2020-09, Vol.7 (9), p.ofaa356-ofaa356

2020

Link zum Volltext

Verfügbarkeit prüfen

The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment - results from an observational study in Germany

Journal of pharmaceutical policy and practice, 2016-12, Vol.9 (1), p.39-39, Article 39

2016

Link zum Volltext

Verfügbarkeit prüfen

GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients

Journal of medical virology, 2008-11, Vol.80 (11), p.1933-1940

2008

Link zum Volltext

Verfügbarkeit prüfen

Pre-TCR signaling components trigger transcriptional activation of a rearranged TCR alpha gene locus and silencing of the pre-TCR alpha locus: implications for intrathymic differentiation

International immunology, 1997-10, Vol.9 (10), p.1475-1480

1997

Link zum Volltext

Verfügbarkeit prüfen

Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings

Clinical Immunology, 2007-10, Vol.125 (1), p.1-4

2007

Link zum Volltext

Verfügbarkeit prüfen

Dichotomous effects of C–C chemokines in HIV-1 pathogenesis

Immunology Letters, 2007-05, Vol.110 (1), p.1-5

2007

Link zum Volltext

Verfügbarkeit prüfen

Higher risk of cytomegalovirus reactivation in human immunodeficiency virus–1–infected patients homozygous for MICA5.1

Human immunology, 2009-03, Vol.70 (3), p.175-178

2009

Link zum Volltext

Verfügbarkeit prüfen

Exogenous HIV-1 Vpr disrupts IFN-α response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay

Immunology letters, 2009-08, Vol.125 (2), p.100-104

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(115)

Publikationsform

Buchkapitel
(57)
Artikel
(39)
Bücher
(20)
Berichte
(1)

Sprache

Deutsch
(78)
Englisch
(47)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Aids
(3)
European Journal Of Immunology
(3)
Muscle & Nerve
(3)
Aids Care
(2)
Immunobiology
(2)
Immunology Letters
(2)
Infection
(2)
International Immunology
(2)
Journal Of Hepatology
(2)
Aids Research And Human Retroviruses
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Geht der Trend nun zur Zweierkombination?

Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study

CCL2: A potential prognostic marker and target of anti‐inflammatory strategy in HIV/AIDS pathogenesis

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals

Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline

Barriers to hepatitis C virus elimination in Germany: why aren’t diagnosed patients initiating therapy?

SAT286 - Barriers to hepatitis C virus elimination in Germany: why aren’t diagnosed patients initiating therapy?

Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir: a DUALIS sub-study

Treatment of HIV-1 infection: is it time to hit early again?

Infection with GB Virus C and Reduced Mortality among HIV-Infected Patients

High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany

Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines

Reconstitution of NK Cell Activity in HIV-1 Infected Individuals Receiving Antiretroviral Therapy

Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study

The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment - results from an observational study in Germany

Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir: a DUALIS sub-study

GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients

Pre-TCR signaling components trigger transcriptional activation of a rearranged TCR alpha gene locus and silencing of the pre-TCR alpha locus: implications for intrathymic differentiation

Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings

Dichotomous effects of C–C chemokines in HIV-1 pathogenesis

Higher risk of cytomegalovirus reactivation in human immunodeficiency virus–1–infected patients homozygous for MICA5.1

Exogenous HIV-1 Vpr disrupts IFN-α response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay

Suchergebnisse filtern